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Type 3 haemochromatosis (HFE3) is a rare genetic iron overload disease which ultimately lead to compromised organs functioning.
HFE3 is caused bymutations in transferrin receptor 2 (TFR2) gene that codes for twomain isoforms (Tfr2𝛼 and Tfr2𝛽). Tfr2𝛼 is one
of the hepatic regulators of iron inhibitor hepcidin. Tfr2𝛽 is an intracellular isoform of the protein involved in the regulation of iron
levels in reticuloendothelial cells. It has been recently demonstrated that Tfr2 is also involved in erythropoiesis. This study aims to
further investigate Tfr2 erythropoietic role by evaluating the erythropoiesis of two Tfr2 murine models wherein either one or both
of Tfr2 isoforms have been selectively silenced (Tfr2 KI and Tfr2 KO).The evaluations were performed in bone marrow and spleen,
in 14 days’ and 10 weeks’ old mice, to assess erythropoiesis in young versus adult animals. The lack of Tfr2𝛼 leads to macrocytosis
with low reticulocyte number and increased hemoglobin values, together with an anticipation of adult BM erythropoiesis and
an increased splenic erythropoiesis. On the other hand, lack of Tfr2𝛽 (Tfr2 KI mice) causes an increased and immature splenic
erythropoiesis. Taken together, these data confirm the role of Tfr2𝛼 in modulation of erythropoiesis and of Tfr2𝛽 in favoring iron
availability for erythropoiesis.
1. Introduction
Type 3 haemochromatosis (HFE3) is an autosomal recessive
genetic disorder that leads to an accumulation of iron both in
the blood and in several tissues, especially in the liver. Because
of this, HFE3 patients have elevated transferrin saturation
(TS) and serum ferritin level (sFt) [1].
This disease is caused bymutations in transferrin receptor
2 (TFR2) gene [2] that codes for two main isoforms, namely,
Tfr2 alpha (Tfr2𝛼) and Tfr2 beta (Tfr2𝛽), that showmoderate
homology to the type 1 transferrin receptor (Tfr1) [3]. Unlike
Tfr1, TFR2 gene expression itself is not directly regulated by
iron [4] and TFR2 mRNA does not have iron responsive
elements (IREs). Thus, there is no IRE-dependent posttran-
scriptional regulation of the protein levels [5]. Several in vitro
studies have demonstrated that Tfr2𝛼 can bind iron loaded
transferrin, however, with an affinity remarkably lower than
that of Tfr1 [3]. Additionally, the levels of this protein in
plasma membrane are regulated by TS, with an increased
stabilization in the presence of highly saturated transferrin [6,
7]. The transcription of the entire TFR2 gene gives rise to the
Tfr2𝛼 isoform which is a transmembrane protein. Tfr2𝛽, on
the other hand, is a shorter isoform lacking the cytoplasmic
and transmembrane domains, and it is currently unknown
if its activity is intracellular or extracellular. The expression
patterns of these two isoforms are also very different. Tfr2𝛼
is highly transcribed in the liver and in erythroleukemic cell
line (K562), while Tfr2𝛽 is mainly transcribed in liver, brain,
heart [3], and splenicmacrophages [8].Most TFR2mutations
compromise the production of both Tfr2 isoforms. However,
some mutations affect only the Tfr2𝛼 isoform, while others,
such as M172K, abolish the Tfr2𝛽methionine starting codon
[9, 10].
Studies on murine models of HFE3 have demonstrated
that Tfr2𝛼 and Tfr2𝛽 isoforms have distinct functions in iron
homeostasis. While Tfr2𝛼 is involved in the hepatic pathway
regulating iron hormone hepcidin (Hamp) [7], Tfr2𝛽 is
involved in iron efflux from reticuloendothelial cells [8].
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A recent study has demonstrated that the Tfr2𝛼 isoform is
also expressed in erythroid progenitors. Here, it interacts
with and stabilizes the erythropoietin receptor (EpoR), hence
establishing a correlation between Tfr2𝛼 and erythropoiesis
for the first time [11]. Furthermore, it is thought to be directly
involved in the mechanisms of control of erythropoiesis,
especially in conditions of iron deprivation [12, 13].
It is well known that erythropoiesis, as well as iron
demand, changes throughout life in humans as a consequence
of an increase in blood volume. Also, complete blood cell
count (CBC) values differ slightly depending upon the age
[14]. To our knowledge, no data exist to date on variations
in erythropoiesis during ageing in mice. Some regulators
of erythropoiesis have been characterized in recent years.
One of them, named Erythroferrone (Erfe), is a hormone
produced by erythroblasts that is able to regulate Hamp levels
as a consequence of erythropoietic demand due to blood loss
[15] or anemia of inflammation [16].
To investigate how Tfr2𝛼 silencing influences erythrocyte
production across lifespan inmice, we studied erythropoiesis
in two primary erythropoietic organs, the bonemarrow (BM)
and the spleen, at different ages using twomousemodels with
inactivated Tfr2𝛼 and/or Tfr2𝛽. The findings of this study
could be an important step toward gaining a better insight
into Tfr2 involvement in erythropoiesis in humans.
Our results indicate that the lack of Tfr2𝛼 influences BM
and splenic erythropoiesis starting from an early stage of life.
Moreover, Tfr2𝛽 also influences erythropoiesis by the mod-
ulation of iron availability for erythrocyte maturation. More
importantly, we now show that Erfe expression is regulated
by erythropoiesis not only in adult animals, as previously
demonstrated [15], but also in young age. Additionally, Erfe
appears to be negatively modulated by erythropoietic tissues’
iron availability. Lastly, we also describe the physiological
variations of erythropoietic activity in WT mice during
ageing.
2. Materials and Methods
2.1. Animals. Two Tfr2 mouse models on 129X1/svJ strain
were studied: (1) Tfr2 KI that has the Tfr2𝛽 isoform inacti-
vated (𝛼+𝛽0) and (2) Tfr2 KO that has both Tfr2 isoforms
inactivated (𝛼0𝛽0). Selective targeting of Tfr2 isoforms was
obtained starting from the same target construct in which
murine M163K mutation (homologous to M172K human
variant) was inserted in murine Tfr2 gene exon 4 flanked by
3 loxP sites activated through Cre/lox recombination system
[8].
At adult age (10 w), Tfr2 KI mice have normal Hamp
and normal serum iron parameters but splenic iron overload,
while Tfr2 KO animals have normal Hamp but high serum
ferritin and transferrin saturation as well as hepatic iron
overload [8].
All animals were housed at Department of Veterinary
Sciences, University of Torino. Animal housing and all the
experimental procedures were performed in accordance with
European (Official Journal of the European Union L276
del 20/10/2010, Vol. 53, p. 33–80) and National Legislation
(Gazzetta Ufficiale n∘ 61 del 14/03/2014, p. 2–68) for the pro-
tection of animals used for scientific purposes.
Tfr2-targeted mice and controls were maintained on
standard conditions and with ad libitum access to food and
water. They were analyzed at 14 days and 10 weeks of age.
Onlymalemice were used in this study tominimize potential
variability related to sex.
At least 6 animals were analyzed for each experimental
condition.
2.2. Hematological Analysis. Peripheral blood from the ani-
mals was subjected to complete blood cell count (CBC) anal-
ysis. Hemoglobin concentration (HB), hematocrit (HCT),
erythrocytes number (RBC), and other indices (MCV,
MCH, MCHC, and reticulocytes) were measured using an
ADVIA120 Hematology System (Siemens Diagnostics).
2.3. Flow Cytometry. Spleen and bone marrow (BM) were
extracted from sacrificed animals and used for flow cyto-
metric analysis using APC-Ter119 and PE-CD71. Fc-receptor
was previously blocked using anti-mouse CD16/CD32; a
mix of FITC-conjugated lymphoid and myeloid markers
(CD3e, CD45R, CD41, CD11b, and Gr-1) was used to exclude
leukocytes and 7-AAD was used to exclude dead cells. All
reagents were purchased from eBiosciences. Ter119-positive
events were allocated into five subsets representing sequential
maturation stages (ProE, EryA, EryB, and EryC), according
to CD71 intensity and FSC properties [17–19]. An EryD
region was added according to the results by Chen et al.,
who localized a gate where orthochromic erythroblasts with
nuclear-cytoplasmic dyssynchrony fall [19].
2.4. Histology and Perl’s Staining. Animals livers and spleens
were explanted, fixed in 4% PFA, cryoprotected by a sucrose
gradient (7.5%, 15%, and 30%), and embedded in OCT prior
to cryosectioning at 30 𝜇m. Tissue sections were stained with
Perl’s Prussian blue method (Bio-Optica). Images were taken
at 20x magnification using a LEICA DFC208 microscope.
2.5. Monocytes/Macrophages Isolation. For each group (Tfr2
KI, Tfr2 KO, and control litter-mates), monocytes/macro-
phages were separated from a pool of 4 spleens using MACS
CD11b MicroBeads (Milteni Biotec).
2.6. Molecular Analysis. Hamp gene expression was evalu-
ated in Tfr2 targeted and in WT mouse liver. For reverse-
transcription, 1𝜇g of total RNA, 25 𝜇M random hexamers,
and 100Uof reverse transcriptase (Applied Biosystems, USA)
were used.
Hamp expression levels were measured by quantita-
tive real-time reverse-transcription (RT-PCR) with CFX96
Real-Time System (BIO-RAD) using a quantitative RT-PCR
assay (Assays-on-Demand; Applied Biosystems, USA). Erfe
expression was evaluated using SYBR Green PCR technol-
ogy (EVAGreen, BIO-RAD) using the following primers:
mErfe F1 5󸀠ATGGGGCTGGAGAACAGC3󸀠 and mErfe R1
5󸀠TGGCATTGTCCAAGAAGACA3󸀠. All analyses were car-
ried out in triplicate and results showing a discrepancy greater
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than 1 threshold cycle in 1 of the wells were excluded. Gus
(𝛽-glucuronidase) gene was used as housekeeping control.
The results were analyzed using the ΔΔ threshold cycle (𝐶
𝑡
)
method [20].
Western blots of BM, spleen, and monocytes/macro-
phages lysates (50 𝜇g) for Cleaved Caspase-3 (5A1E, Cell
Signaling), Bcl-xL (H-5), divalentmetal transporter 1 (DMT1)
(H-108), Fpn1 (G-16), Tfr2 (S-20), 𝛽-actin (C-4) (Santa Cruz
Biotechnology), and Ft-L (kindly provided by S. Levi, Milan)
proteins were performed through standard protocols.
Data from Western blot quantification (Image Lab Soft-
ware, BIO-RAD) were obtained after normalizing on 𝛽-actin
levels and expressed as fold increase, relative to the mean
value obtained from the WT mice.
2.7. Statistical Analysis. For hematological analysis and flow
cytometry experiments, statistical comparisons among geno-
types and age groups were performed using nonparametric
tests (Kruskal-Wallis or Mann–Whitney, resp.) using SPSS
version 21 software. Differences of mRNA expression and
protein production between controls and targeted mice were
evaluated with a nonparametric Student’s 𝑡-test (unpaired,
two-tailed) using GraphPad Prism software. 𝑃 < 0.05 was
considered to be statistically significant.
3. Results
3.1. Peripheral Blood Cell Count. The pattern of erythro-
poiesis was observed to be different in WT and Tfr2 mice
across the lifespan.Additionally, Tfr2mice showed significant
variations in erythropoiesis compared to age-matched WT
controls in the CBC assay.
3.1.1. Young versus Adult Animals. 14 d old mice had lower
RBC, HB, and HCT and higher MCV and reticulocytes
compared to adults in all genotypes analyzed (Figure 1).
Young WT mice showed similar MCH but lower MCHC
as compared to adult WT mice, demonstrating that normal
mouse erythropoiesis during animal growth follows the same
trend as that of normal human erythropoiesis [14].
Young Tfr2 KI and KO mice demonstrated higher MCH
but similar MCHC compared to adult animals with the same
genotype (Figure 1).Thus, youngTfr2mice have increased the
levels of hemoglobin in RBC compared to age-matched WT
animals. However, the differences are statistically significant
only in Tfr2 KO mice.
3.1.2. Young Tfr2 Mice. The comparison of 14 d old Tfr2 KI
to WT mice did not reveal any significant differences in all
CBC parameters analyzed. On the contrary, 14 d old Tfr2 KO
mice had higher RBC, HB, HCT, MCH, and MCHC values
than age-matched WT mice (significant differences for HB,
MCH, and MCHC only) (Figures 1(b), 1(e), and 1(g)) and a
significantly lower number of reticulocytes (Figure 1(f)).
To investigate if this difference in the number of retic-
ulocytes in young Tfr2 KO animals could be due to an
alteration of the apoptosis pathway in the BM, we analyzed
Cleaved Caspase-3 (CC-3) [21] and Bcl-xL [22]. The level of
the proapoptotic marker CC-3 was comparable to that of age-
matched WT mice, while the antiapoptotic marker Bcl-xL
increased about 1.5-fold in Tfr2 KO young animals versus
WT (Figure S1 A, in Supplementary Material available online
at https://doi.org/10.1155/2017/2408941). In conclusion, an
increase in apoptotic death is not the underlying cause for the
decreased reticulocyte production in these animals.
3.1.3. Adult Tfr2 Mice. Adult Tfr2 KI animals had signifi-
cantly higher number of RBC but lower MCH and MCHC
compared to age-matched WT (Figures 1(a), 1(e), and 1(g));
however, these differences were not statistically significant.
Adult Tfr2 KO mice had statistically significantly
increased MCV and MCH compared to WT litter-mates
of the same age (Figures 1(d) and 1(e)). All the other CBC
parameters were comparable to those of age-matched WT
animals.
3.2. BM and Spleen Erythropoiesis. Flow cytometry analysis
of the BM and spleen erythropoiesis revealed several unex-
pected results in both young and adult animals.
The BM erythropoiesis was increased in adult mice
compared to the young ones (Figure 2(a)) in WT and KI
mice alike. In contrast, Tfr2 KO mice had high levels of
erythropoiesis already at 14 d of age, with values similar to
adults (Figure 2(a)).
Both Tfr2 KI and Tfr2 KO 14 d old mice had increased
splenic erythropoiesis compared to age-matchedWT, though
the difference was statistically significant only for the Tfr2 KO
group. Interestingly, splenic erythropoiesis similarly reduced
in adulthood for the two genotypes, reaching comparable
values to the WT (Figure 2(b)).
From the qualitative point of view, no evident differences
were found in the BM of young Tfr2 mice except for a higher
number of EryD cells in Tfr2 KO (Figure 2(c)). Unexpectedly,
an enhanced splenic erythropoiesis was observed in young
Tfr2 KI mice, characterized by a left shift in the erythroid
lineage resulting in a higher number of precursor erythroid
cells and a lower number of mature cells (Figure 2(d)). Sim-
ilarly, young Tfr2 KO mice also presented increased splenic
erythropoiesis, as mentioned above (Figure 2(b)). However,
no statistically different values were found compared to WT
(Figure 2(d)).
Surprisingly, the erythropoiesis in adult Tfr2 KO mice
wasmarkedly altered. Although an increase in the percentage
of early precursors (Figures 2(c) and 2(d)) was found, no
reticulocytosis could be seen in these mice. This could be
because of an increase in apoptosis as is evidenced by the
doubling of the levels of the apoptotic marker Caspase-3 in
adult Tfr2 KO mice compared to age-matched WT. On the
contrary, the antiapoptotic marker Bcl-xL was significantly
decreased in Tfr2 KO mice compared to WT (Figure S1 B).
Finally, flow cytometry analysis revealed that in both
young and adult Tfr2 KO mice CD71 MFI was significantly
lower compared to WT in BM as well as in the spleen and
in all erythroid maturation stages except for EryC in adult
animals. CD71 MFI in Tfr2 KO mice was lower compared to
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Figure 1: (a) Red blood cells (RBC; ×10E06 cells/𝜇L), (b) hemoglobin concentration (HB; g/dL), (c) hematocrit (HCT; %), (d) mean
corpuscular volume (MCV; fL), (e) mean corpuscular hemoglobin (MCH; pg), (f) reticulocytes (retic; ×10E09 cells/L), and (g) mean
corpuscular hemoglobin concentration (MCHC; g/dL) values obtained from animals CBC. WT: wild type (blue); KI: Tfr2 KI (green); KO:
Tfr2 KO (yellow); 14 d: 14 days; 10 w: 10 weeks. ∗ ∘ ∧ indicate statistically significant differences (𝑃 < 0.05) compared to age-matched WT,
KO, and KI, respectively.
KI mice for EryC in young animals and for EryA and EryB in
adults (Figure S2).
3.3. Iron Levels in Tfr2 Animals. Since iron availability could
influence erythropoietic stimulus, we analyzed the iron levels
and hepatic Hamp production in erythropoietic tissues of
Tfr2 animals as compared to controls.
Perl’s histological staining (Figures 3(a) and 3(b)) revealed
surprisingly high iron levels in livers from Tfr2 KO mice
already at 14 d of age (Figure 3(a)) and, as expected, in adult
animals as well (Figure 3(b)). In contrast, no significant liver
iron deposit was visible in Tfr2 KI young and adult animals
(Figures 3(a) and 3(b)). A significant splenic iron overload
was evidenced only in Tfr2 KI adult animals (Figure 3(b)).
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Figure 2: Flow cytometry analysis of quantitative (a, b) and qualitative (c, d) erythropoiesis in bonemarrow (BM) and spleen of 14 days (14 d)
and 10 weeks (10w) oldmice.WT: wild type; KI: Tfr2 KI; KO: Tfr2 KO. ProE, EryA, EryB, EryC, and EryD represent sequential erythropoietic
maturation stages. ∗ ∧ indicate statistically significant differences (𝑃 < 0.05) compared to age-matched WT and KI, respectively.
BM iron staining with Perl’s did not reveal any obvious
large iron deposit (data not shown). In addition, L ferritin
(Ft-L) levels were found to be significantly elevated in the
BM of both Tfr2 young mice (Figure 3(c)). However, during
adulthood, it remained high only in the BM of Tfr2 KO mice
(Figure 3(d)).
3.4. Hamp and Erfe Analysis. The hepatic Hamp expression
was significantly decreased in Tfr2 KI and KO animals
compared to age-matched WT litter-mates. The same was
true for adult animals, although to a lesser degree (Figures
4(a) and 4(b)).
Additionally, Erfe transcript levels were significantly dif-
ferent in the three genotypes: they were significantly higher
in the BM and the spleen of young Tfr2 KI animals and
significantly lower in young Tfr2 KO mice as compared to
WT (Figures 4(c) and 4(d)). In adult Tfr2 KI and KO mice,
Erfe transcription was similar to adult WT in both tissues
analyzed (Figures 4(c) and 4(d)).
Longitudinal comparison between the two ages revealed
that Erfe transcription was significantly increased in the
young compared to genotype matched adult mice, with the
exception of Tfr2 KO BM, whose Erfe amount remained
constant during the growth period of the animal (Figures 4(c)
and 4(d)).
3.5. Erythropoietic Tissues Monocytes. To unravel the role
of Tfr2𝛽 isoform in the iron flux in macrophages during
erythropoiesis, this cell type was isolated from the spleen of
WT and Tfr2 targeted mice at the two experimental time
points. Tfr2𝛽 levels were evaluated, together with the main
proteins involved in cellular iron traffic, namely, the iron
deposit protein ferritin (Ft-L), the iron importer DMT1, and
the iron exporter Ferroportin 1 (Fpn1).
In WT mice, Tfr2𝛽 isoform was observed to decrease in
splenic macrophages of adult animals as compared to the
young ones (Figure 5(a)). In the same cells, DMT1 and Fpn1
decreased as well, while Ft-L levels increased (Figure 5(b)).
In young Tfr2 KI mice, splenic macrophages presented
a lower DMT1 and higher Fpn1 and Ft-L compared to age-
matched WT sib pairs (Figure 5(b)). During the growth
period, DMT1 and Ft-L consistently increased while Fpn1
significantly decreased.
On the other hand, in young Tfr2 KO mice, splenic
macrophages presented a lower DMT1 and Fpn1 and com-
parable Ft-L in comparison to age-matched WT sib pairs
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Figure 3: Perl’s Prussian blue staining of liver and spleen sections from wild type (WT), Tfr2 KI (KI), and Tfr2 KO (KO) animals at (a) 14
days (14 d) and (b) 10 weeks (10w) of age.Western blot analysis shows ferritin L (Ft-L) protein production in bonemarrow ofWT, KI, and KO
mice at (c) 14 days (14 d) and (d) 10 weeks (10w) of age. a.u.: arbitrary unit.The following symbols indicate statistically significant differences:
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001 compared to age-matched WT mice.
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Figure 4: Hepcidin (Hamp) gene expression in Tfr2 targeted and in WT mouse liver at (a) 14 days (14 d) and (b) 10 weeks (10w) of age.
Erythroferrone (Erfe) gene expression in bone marrow (c) and spleen (d) of WT, KI, and KO mice at 14 days (14 d) and 10 weeks (10w) of
age. WT: wild type; KI: Tfr2 KI; KO: Tfr2 KO. The following symbols indicate statistically significant differences: ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01
compared to age-matchedWTmice; ∧𝑃 < 0.05, ∧∧𝑃 < 0.01, and ∧∧∧𝑃 < 0.001 compared to animals with the same genotype at 14 days of age.
(Figure 5(b)). During the growth period, DMT1 and Fpn1
decreased while Ft-L was obviously increased.
4. Discussion
It is well known that iron is essential for adequate ery-
thropoiesis. In the condition of iron deficiency, the most
important pathway that is impaired is RBC production,
firstly in the bone marrow (BM) followed by the spleen.
Erythropoiesis itself undergoes physiological changes that
reflect the requirements of an organism throughout its
lifespan. It increases during youth, when there is massive
body growth, but remains roughly constant during adult life
and tends to decrease during ageing [23–25]. The adequate
iron availability for this dynamic erythropoiesis is achieved
through the modulation of hepcidin, one of the chief iron
regulators [7].
Among the different hepcidin regulators, transferrin
receptor 2 alpha (Tfr2𝛼) has been shown to play a role as an
iron sensor in the liver [7] and as erythropoiesis regulator
in erythropoietic tissues [26]. Notably, the gene encoding
TFR2 is transcribed in two main isoforms: the alpha form,
expressed in the liver and few other tissues, and the shorter
beta form, with a low ubiquitous expression. However, it is
found to be in significantly higher levels in the spleen [3]. In
the liver, Tfr2𝛼 exerts its action on the plasma membrane. It
is not directly responsive to iron levels [4] but is stabilized on
plasmamembrane by iron loaded transferrin [27]. According
to the most recent functional models, hepatic Tfr2𝛼 interacts
with the other iron proteins as Tfr1 and Hfe, to sense body
iron levels and to transduce the signal of iron excess through
the activation of the Smad 1/5/8 and/or the Erk1/2 pathways,
causing an increase in the hepatic hepcidin [7].
Recent data has demonstrated that Tfr2𝛼 also has an
extrahepatic function. It is well expressed in BM, where it
interacts with erythropoietin receptor (EpoR), thereby being
involved in regulation of erythropoiesis [11]. Further, several
studies have demonstrated the role of Tfr2𝛼 in regulating
RBC production in mouse models, particularly in condition
of iron deficiency [12, 13, 28].
In contrast, very little is known about the function of
the second TFR2 isoform, Tfr2𝛽. It is significantly produced
in splenic macrophages and its silencing in the Tfr2 KI
mice does not cause any variation in serum iron parameters
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Figure 5: (a) Comparison between 14-day (14 d) and 10-week (10w) Tfr2𝛽 expression (on the left) and production (on the right) in splenic
macrophages of wild type (WT) animals. (b) Quantification of divalent metal transporter 1 (DMT1), Ferroportin 1 (Fpn1) and ferritin L (Ft-L)
protein production resulting fromWestern blot analysis of splenic macrophages isolated fromWT, KI, and KOmice at 14 d and 10w of ages.
a.u.: arbitrary unit; SPL: total spleen. ∗ indicates statistically significant difference (𝑃 < 0.05).
and liver iron content. Nevertheless, these animals present
iron retention in the macrophages probably through the
downregulation of iron exporter Fpn1 [8].
Therefore, in the presentmanuscript, we aimed to analyze
the role of both Tfr2 isoforms in erythropoiesis and the
contribution of available iron in the modulation of ery-
thropoiesis. We used the Tfr2 KI animals (𝛼+𝛽0), in which
circulating iron levels are normal, and the Tfr2 KO mice
(𝛼0𝛽0), that have severe iron overload in addition to increased
serum ferritin and transferrin saturation. We compared the
erythropoiesis in these animals to that of WT litter-mates.
Furthermore, we evaluated these two Tfr2 mouse models at
young age (14 d), when iron demand is high to fulfill growth
requirements, and at adult age (10 w), when iron is needed
primarily for themaintenance of erythropoiesis. Our findings
demonstrate that adult Tfr2 KOmice show normal erythroid
parameters at CBC except for an increasedMCV and a higher
hemoglobin content (MCH). This indicates that, in Tfr2 KO
mice, the maximum amount of HB is produced in the RBC
in the early stages of erythropoiesis, when cells are larger. On
the contrary, in WT animals, the same hemoglobin amount
reaches the final concentration through the reduction of
RBC dimension. This phenomenon could be associated with
an attempt of the body to eliminate the excess iron. In
the same animals, BM and splenic erythroid production
is quantitatively normal, but it is characterized by a shift
toward immature precursors. The left shift in the maturation
sequence could be an evidence of a delayed erythropoiesis
in accordance with the results of previous studies [12, 13].
On the other hand, lack of reticulocytosis in these animals
can be explained by an increase in the total BM apoptosis,
confirmed by an increase of apoptotic marker Caspase-3 and
a simultaneous decrease of the antiapoptotic protein Bcl-xL.
This could represent a late stage control mechanism that may
account for the depletion of late precursors that is ultimately
responsible for an ineffective erythropoiesis.
Importantly, these findings are in contrast with the study
by Nai et al., in which BM specific Tfr2 KO mice (Tfr2BMKO)
present an increased number of RBCs, decreased volume and
hemoglobin content, and increased splenic stress erythro-
poiesis, in the presence of normal serum iron parameters
[28].
The primary genetic differences between these two mod-
els are that Tfr2BMKO mice maintain Tfr2𝛼 and 𝛽 isoforms
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function in the other body organs, particularly in the liver and
in the spleen, whereas Tfr2 KO mice have a total silencing of
both that causes an increased iron availability.
Therefore, the comparison between these two animal
models is useful to unravel the role of iron in inducing RBC
production in both the BM and the spleen. It is clear from the
data that an increased iron availability in Tfr2 KOmice causes
erythropoiesis, since 14 d oldTfr2KOanimals already have an
erythropoietic activity similar to adult WTmice. In addition,
it also causes erythropoietic changes, an increased number
of immature cells, and increased apoptosis, as is evident in
Tfr2 KO adult animals compared to age-matched WT. The
increased iron levels in the BM of Tfr2 KO animals could
trigger EryA erythroblasts production, but the increased
apoptosis finally normalizes RBC output. Also, the presence
of macrocytosis together with a low reticulocytes number
and increased BM apoptosis in Tfr2 KO mice resembles the
erythropoiesis of myelodysplastic syndromes (MDS) [29]. In
these conditions, iron overload has been demonstrated to
have a causative role. In fact, iron chelation of these MDS
patients ameliorates their BM dysfunction [30].
It would be interesting to induce iron normalization in
the Tfr2 KO animals to evaluate if a phenotype comparable
to that of Nai et al. [28] can be achieved.
Another important difference between the two models is
related to erythropoietic regulator Erythroferrone (Erfe) [15].
Erfe levels are increased in Tfr2BMKO mice while decreased
in our Tfr2 KO animals. Erfe increases due to an increased
iron demand for erythropoiesis and causes a downregulation
of hepcidin [28]. However, to our knowledge, this is the first
time it has been demonstrated that Erfe reduction can also
be a consequence of an adequate erythropoiesis, as we could
observe in Tfr2 KO young animals.
Furthermore, the trend of Erfe in animals of different ages
in both WT and Tfr2 targeted animals is very interesting. It
clearly appears that Erfe has an important role in erythro-
poiesis regulation not only at adult age, as has been already
demonstrated [16], but also at young age. Also, its expression
correlates very well with erythropoietic boost inWT animals,
being high in 14 d old animals and decreasing significantly in
adult animals. Notably, BM and splenic Erfe transcription is
significantly reduced in young Tfr2 KO animals and remains
constant during their growth period, in agreement with the
early achievement of adult erythropoiesis pattern in these
mice.
The relationship between Erfe and Tfr2 has been demon-
strated through several experimental approaches [13, 28].Our
data shows that this relationship is far more evident in young
animals.Moreover, we demonstrate that the presence of Tfr2𝛼
in the liver is essential to have the hepcidin response to Erfe.
In fact, Hamp is decreased in response to an increase of Erfe
in Tfr2 KI mice, that produces the Tfr2 alpha isoform, as
expected. Similarly, in Tfr2BMKO animal model, a decreased
Erfe amount corresponds to and increases Hamp level [28].
On the contrary, in Tfr2 KO animals, in which Tfr2𝛼 is absent
in the liver, Hamp does not increase in response to low Erfe
levels.
Lastly, the lack of Tfr2𝛽 leads to an evident splenic iron
accumulation only in adult Tfr2 KI animals, as previously
demonstrated [8]. Furthermore, it is surprising to see that
lack of Tfr2𝛼 causes an iron accumulation as early as 14 d of
age in the liver of Tfr2 KO animals.
We have focused at least a part of our analysis on young
animals because very little is known about erythropoiesis at
this stage of life even in WT animals. It is important to note
that in the latter the erythropoietic stimulus is mainly iron-
dependent, since an adult erythropoiesis becomes evident in
iron enriched Tfr2 KO young animals.
Surprisingly, the data from the analysis of erythropoiesis
in Tfr2 KI mice at young age is the most interesting, when
these animals present normal serum iron parameters, normal
BM and splenic iron amount, and normal CBC. In spite
of this, their splenic erythropoiesis appears to be increased
and immature compared to age-matched WT.These data are
supported by a significant increase of BM and splenic Erfe
as well. Tfr2 KO mice also present an early increased splenic
erythropoiesis but it is qualitatively normal. This could be a
consequence of the increased circulating iron availability that
can ensure a qualitatively normal but relatively high splenic
erythropoietic maturation.
Next, we hypothesized that enhanced splenic immature
erythropoiesis in the absence of Tfr2𝛽 in young Tfr2 KI
mice could be caused by low iron availability because of
iron retention in splenic macrophages. This situation should
have been evident in the spleen, where reticuloendotelial cells
are particularly abundant. So, to confirm this hypothesis, we
evaluated iron levels in splenic monocytes of Tfr2 mice. We
detected an increase in ferritin and a decrease in Fpn1 in the
splenicmonocytes of youngTfr2KI andKO compared toWT
age-matched mice, which confirms our hypothesis.
Interesting speculations can bemade from this analysis of
the evolution of splenic erythropoiesis during the lifespan of
animals.
From the analysis of WT animals, it is evident that the
spleen eventually loses its role as erythropoietic organ and
becomes a deposit site for iron, that derives from erythrocyte
catabolism. Ft-L in fact increases in splenicmonocytes ofWT
mice during ageing due to Fpn1 decrease.
The same is true in Tfr2 mice’s splenic monocytes, but
here the increase of iron is far more evident in splenic
monocytes of adult Tfr2 KI mice compared to age-matched
WT and Tfr2 KO. Also, iron importer DMT1 is increased
in the splenic monocytes of Tfr2 KI mice. Thus, it could
be interesting to further investigate the relationship between
Tfr2𝛽 and this divalent metal transporter.
On the basis of the data obtained in the present
manuscript, a model for the role of iron in the stimulation of
erythropoiesis at different ages and the involvement of Tfr2
isoforms in erythropoietic organs is illustrated in Figure 6.
5. Conclusions
An analysis of erythropoiesis in mice with inactivation
of one or both of Tfr2 isoforms confirms that there is a
specific function of Tfr2𝛼 in erythropoiesis, which has been
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Figure 6: Model depicting the involvement of iron and Tfr2 isoforms in erythropoiesis. (a) In young (14 d) WT mice, erythropoiesis takes
place in both bonemarrow (BM) and spleenwhile in adult animals, BMerythropoiesis is predominant as compared to splenic RBCproduction
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BioMed Research International 11
previously demonstrated aswell. Germinal lack of Tfr2𝛼 (Tfr2
KO) causes an anticipation of adult erythropoiesis in young
mice in both BM and the spleen. On the other hand, lack of
Trf2𝛽 is responsible for an increased but immature splenic
erythropoiesis that is normalized during animal growth.This
effect due to Trf2𝛽 absence in Tfr2 KO mice is compensated
by the increased amount of circulating iron available for
erythrocyte production.
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